Current role of β-adrenergic blockers in the treatment of chronic congestive heart failure

American Journal of Health-System Pharmacy

Volumn 58, Issue 2, 2001, Pages 140-145

  Smith, A J ^a   Wehner, J S ^a   Manley, H J ^a   Richardson, A D ^a   Beal, J ^a   Bryant, P J ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Bisoprolol; Bucindolol; Cardiac drugs; Carvedilol; Heart failure; Metoprolol; Mortality; Sympatholytic agents; Toxicity

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CARVEDILOL; METOPROLOL;

ADRENERGIC SYSTEM; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG METABOLISM; HUMAN; MEDICAL SOCIETY; MORTALITY; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0035863173     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/58.2.140     Document Type: Article

References (24)

1. Consensus recommendation for the management of chronic heart failure
2. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
3. Hormones and hemodynamics in heart failure
4. Beneficial effects of metoprolol in idio-pathic dilated cardiomyopathy
5. Three-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial
6. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF)
7. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: The metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group
8. A randomized trial of β-blockade in heart failure
9. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomized trial
10. Design of the Beta-blocker Evaluation Survival Trial (BEST)
11. Summary of best (Beta-blockers evaluation survival trial)
12. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
13. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
14. Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure
15. Beta-blockade in heart failure: A comparison of carvedilol with metoprolol
16. Carvedilol: Therapeutic application and practice guidelines
17. Beta-adrenergic blocking agents in heart failure: Benefits of vasodilating and non-vasodilating agents according to patients' characteristics: A meta-analysis of clinical trails
18. Evaluation of intrinsic sympathomimetic activity of bucindolol and carvedilol in rat heart
19. Beta-receptor active agents: Role of partial agonists in patients with heart failure
20. CARMEN: Carvedilol ACE Inhibitor Remodeling Mild Heart Failure Evaluation